Gut organoids: mini-tissues in culture to study intestinal physiology and disease
- PMID: 31216420
- PMCID: PMC6766612
- DOI: 10.1152/ajpcell.00300.2017
Gut organoids: mini-tissues in culture to study intestinal physiology and disease
Abstract
In vitro, cell cultures are essential tools in the study of intestinal function and disease. For the past few decades, monolayer cellular cultures, such as cancer cell lines or immortalized cell lines, have been widely applied in gastrointestinal research. Recently, the development of three-dimensional cultures known as organoids has permitted the growth of normal crypt-villus units that recapitulate many aspects of intestinal physiology. Organoid culturing has also been applied to study gastrointestinal diseases, intestinal-microbe interactions, and colorectal cancer. These models are amenable to CRISPR gene editing and drug treatments, including high-throughput small-molecule testing. Three-dimensional intestinal cultures have been transplanted into mice to develop versatile in vivo models of intestinal disease, particularly cancer. Limitations of currently available organoid models include cost and challenges in modeling nonepithelial intestinal cells, such as immune cells and the microbiota. Here, we describe the development of organoid models of intestinal biology and the applications of organoids for study of the pathophysiology of intestinal diseases and cancer.
Keywords: colon cancer; genetic editing; gut physiology; intestinal organoids; organoid culture.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
Figures
Similar articles
-
Organoid Models of Human Gastrointestinal Development and Disease.Gastroenterology. 2016 May;150(5):1098-1112. doi: 10.1053/j.gastro.2015.12.042. Epub 2016 Jan 14. Gastroenterology. 2016. PMID: 26774180 Free PMC article. Review.
-
A High-Throughput Organoid Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology.Cell Mol Gastroenterol Hepatol. 2018 May 22;6(3):301-319. doi: 10.1016/j.jcmgh.2018.05.004. eCollection 2018. Cell Mol Gastroenterol Hepatol. 2018. PMID: 30123820 Free PMC article.
-
Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids.Dev Biol. 2016 Dec 15;420(2):262-270. doi: 10.1016/j.ydbio.2016.09.014. Epub 2016 Sep 14. Dev Biol. 2016. PMID: 27640087 Review.
-
Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches.Exp Mol Med. 2020 Feb;52(2):227-237. doi: 10.1038/s12276-020-0386-0. Epub 2020 Feb 26. Exp Mol Med. 2020. PMID: 32103122 Free PMC article. Review.
-
Human intestinal organoids: Modeling gastrointestinal physiology and immunopathology - current applications and limitations.Eur J Immunol. 2024 Feb;54(2):e2250248. doi: 10.1002/eji.202250248. Epub 2023 Nov 28. Eur J Immunol. 2024. PMID: 37957831 Review.
Cited by
-
Applications of human organoids in the personalized treatment for digestive diseases.Signal Transduct Target Ther. 2022 Sep 27;7(1):336. doi: 10.1038/s41392-022-01194-6. Signal Transduct Target Ther. 2022. PMID: 36167824 Free PMC article. Review.
-
Human Organoids for Predictive Toxicology Research and Drug Development.Front Genet. 2021 Nov 1;12:767621. doi: 10.3389/fgene.2021.767621. eCollection 2021. Front Genet. 2021. PMID: 34790228 Free PMC article. Review.
-
ERK3/MAPK6 controls IL-8 production and chemotaxis.Elife. 2020 Apr 21;9:e52511. doi: 10.7554/eLife.52511. Elife. 2020. PMID: 32314963 Free PMC article.
-
Robust differentiation of human enteroendocrine cells from intestinal stem cells.Nat Commun. 2022 Jan 11;13(1):261. doi: 10.1038/s41467-021-27901-5. Nat Commun. 2022. PMID: 35017529 Free PMC article.
-
A foundational approach to culture and analyze malnourished organoids.Gut Microbes. 2023 Dec;15(2):2248713. doi: 10.1080/19490976.2023.2248713. Epub 2023 Sep 19. Gut Microbes. 2023. PMID: 37724815 Free PMC article.
References
-
- Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R, Nag A, Kugener G, Cimini B, Tsvetkov P, Maruvka YE, O’Rourke R, Garrity A, Tubelli AA, Bandopadhayay P, Tsherniak A, Vazquez F, Wong B, Birger C, Ghandi M, Thorner AR, Bittker JA, Meyerson M, Getz G, Beroukhim R, Golub TR. Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560: 325–330, 2018. doi:10.1038/s41586-018-0409-3. - DOI - PMC - PubMed
-
- Beyaz S, Mana MD, Roper J, Kedrin D, Saadatpour A, Hong S-J, Bauer-Rowe KE, Xifaras ME, Akkad A, Arias E, Pinello L, Katz Y, Shinagare S, Abu-Remaileh M, Mihaylova MM, Lamming DW, Dogum R, Guo G, Bell GW, Selig M, Nielsen GP, Gupta N, Ferrone CR, Deshpande V, Yuan G-C, Orkin SH, Sabatini DM, Yilmaz ÖH. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531: 53–58, 2016. [Erratum in Nature 560: E26, 2018.] doi:10.1038/nature17173. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
